Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd09e7f5afaa64980a70db808b717671 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b84b027f66b972feba41fcbe1d43575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95c8f32bae8b364ae55aa8fadbd14f70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ec0cb2c552eb6e132f5b8a9bfbef9a5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2008-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_064a1517c065a9f9640c44c2fa4b1d5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a66e5231aaed94156df9e2f43f27540 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c543f3c8d82ea3056746c07a8ef568b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f683ce0bdf5f36e75c4b428789cedfd |
publicationDate |
2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009274689-A1 |
titleOfInvention |
Co-Administration of a Thrombolytic and an Anti-CD18 Antibody in Stroke |
abstract |
A method for improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size is described which involves administering an effective amount of an anti-CD18 antibody to the mammal, in the absence of removal of the arterial obstruction. |
priorityDate |
1996-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |